We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$80.2B
AUM Growth
+$2.8B
Cap. Flow
+$296M
Cap. Flow %
0.37%
Top 10 Hldgs %
9.83%
Holding
4,048
New
499
Increased
1,419
Reduced
1,452
Closed
416

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$667M
2
NVDA icon
NVIDIA
NVDA
+$584M
3
COP icon
ConocoPhillips
COP
+$432M
4
AMZN icon
Amazon
AMZN
+$418M
5
JNJ icon
Johnson & Johnson
JNJ
+$377M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$836M
2
META icon
Meta Platforms (Facebook)
META
+$525M
3
AAPL icon
Apple
AAPL
+$453M
4
CELG
Celgene Corp
CELG
+$349M
5
PFE icon
Pfizer
PFE
+$306M

Sector Composition

Rank Sector Weight
1 Technology 15.58%
2 Consumer Discretionary 13.65%
3 Healthcare 12.98%
4 Industrials 7.3%
5 Financials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIR icon
3251
AAR Corp
AIR
$5.15B
$317K ﹤0.01%
8,616
-5,476
-39% -$181K
AR icon
3252
Antero Resources
AR
$10.9B
$316K ﹤0.01%
57,125
+41,988
+277% +$303K
MOV icon
3253
Movado Group
MOV
$812M
$315K ﹤0.01%
11,651
-18,153
-61% -$571K
TRIP icon
3254
PUT
TripAdvisor
TRIP
$1.59B
$315K ﹤0.01%
6,800
-10,900
-62% -$531K
ADAP
3255
DELISTED
Adaptimmune Therapeutics
ADAP
$314K ﹤0.01%
77,990
-216,583
-74% -$883K
BMI icon
3256
Badger Meter
BMI
$3.66B
$313K ﹤0.01%
5,237
-29,089
-85% -$1.61M
IRM icon
3257
CALL
Iron Mountain
IRM
$38.2B
$313K ﹤0.01%
10,000
UVV icon
3258
Universal Corp
UVV
$1.34B
$311K ﹤0.01%
5,124
-6,552
-56% -$367K
ITRN icon
3259
Ituran Location and Control
ITRN
$1.08B
$310K ﹤0.01%
10,303
+955
+10% +$32.2K
OGS icon
3260
CALL
ONE Gas
OGS
$5.05B
$307K ﹤0.01%
3,400
+600
+21% +$53.1K
UBA
3261
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$305K ﹤0.01%
14,540
-20,123
-58% -$436K
OPI
3262
DELISTED
Office Properties Income Trust
OPI
$304K ﹤0.01%
11,582
-800
-6% -$21K
AAWW
3263
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$304K ﹤0.01%
6,800
GAIN icon
3264
Gladstone Investment Corp
GAIN
$635M
$303K ﹤0.01%
27,011
-8,792
-25% -$104K
GIII icon
3265
G-III Apparel Group
GIII
$1.47B
$303K ﹤0.01%
+10,310
New +$352K
TBPH icon
3266
Theravance Biopharma
TBPH
$874M
$303K ﹤0.01%
18,539
-16,332
-47% -$331K
XENE icon
3267
Xenon Pharmaceuticals
XENE
$6.32B
$303K ﹤0.01%
30,766
-24,866
-45% -$238K
SIG icon
3268
CALL
Signet Jewelers
SIG
$3.55B
$302K ﹤0.01%
+16,900
New +$363K
SAVE
3269
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$301K ﹤0.01%
+6,300
New +$321K
EMKR
3270
DELISTED
Emcore Corp
EMKR
$301K ﹤0.01%
9,164
+1,414
+18% +$52.6K
FARO
3271
DELISTED
Faro Technologies
FARO
$298K ﹤0.01%
+5,659
New +$286K
NGNE icon
3272
Neurogene
NGNE
$696M
$298K ﹤0.01%
6,318
WW
3273
PUT
DELISTED
WW International
WW
$298K ﹤0.01%
15,600
-7,400
-32% -$147K
BKCC
3274
DELISTED
BlackRock Capital Investment Corporation
BKCC
$297K ﹤0.01%
49,268
-12,876
-21% -$78.9K
JLL icon
3275
PUT
Jones Lang LaSalle
JLL
$15.1B
$295K ﹤0.01%
+2,100
New +$298K

Similar funds

D.E. Shaw & Co's Q2 2019 Portfolio in Review

As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
  • D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
  • D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
  • D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
  • D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
  • D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.